Editas Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	181.82	146.65	131.54	123.65	141.52	203.52
Short-Term Investments	29.83	-	138.37	199.46	202.75	296.33
Cash & Short-Term Investments	211.65	146.65	269.91	323.11	344.27	499.85
Cash Growth	18.57%	-45.67%	-16.46%	-6.15%	-31.12%	24.31%
Accounts Receivable	2.73	15.18	16.27	10.19	5.15	0.27
Receivables	2.73	15.18	16.27	10.19	5.15	0.27
Prepaid Expenses	3.7	2.07	3.14	7.53	7.34	7.2
Total Current Assets	218.07	163.9	289.32	340.83	356.75	507.31
Property, Plant & Equipment	16.32	19.66	47.05	45.71	59.22	43.29
Long-Term Investments	-	-	-	104.02	93.1	120.07
Other Long-Term Assets	2.98	2.98	5.22	8.59	5.25	6.81
Total Assets	237.36	186.53	341.59	499.15	514.32	677.48
Accounts Payable	4.74	2.61	5.49	8.27	9.51	5.05
Accrued Expenses	11.76	24.84	44.1	34.56	31.3	20.19
Current Portion of Leases	6.51	6.03	14.65	12.16	11.08	10.31
Current Unearned Revenue	39.82	5	11.22	8.22	8.22	11.33
Other Current Liabilities	5.61	7.77	1.76	-	-	-
Total Current Liabilities	68.43	46.25	77.23	63.22	60.11	46.88
Long-Term Leases	9	12.07	20.38	24.37	32.86	16.07
Long-Term Unearned Revenue	52.24	98.11	106.64	60.67	60.67	60.89
Other Long-Term Liabilities	2.41	2.82	3.07	1.8	-	-
Total Liabilities	132.08	159.25	207.32	150.06	153.64	123.84
Common Stock	0.02	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	1,777	1,656	1,602	1,580	1,442	1,412
Retained Earnings	-1,672	-1,629	-1,468	-1,231	-1,078	-857.7
Comprehensive Income & Other	-0.01	-	0.27	0.2	-3.6	-0.49
Total Common Equity	105.28	27.29	134.27	349.1	360.68	553.64
Shareholders' Equity	105.28	27.29	134.27	349.1	360.68	553.64
Total Liabilities & Equity	237.36	186.53	341.59	499.15	514.32	677.48
Total Debt	15.51	18.1	35.03	36.54	43.95	26.38
Net Cash (Debt)	196.13	128.54	234.88	390.6	393.43	593.54
Net Cash Growth	24.64%	-45.27%	-39.87%	-0.72%	-33.72%	22.22%
Net Cash Per Share	1.94	1.45	2.85	5.14	5.73	8.78
Filing Date Shares Outstanding	153.58	97.87	82.98	81.81	67.47	68.46
Total Common Shares Outstanding	153.53	97.87	82.73	81.77	67.35	68.44
Working Capital	149.63	117.65	212.09	277.61	296.64	460.43
Book Value Per Share	0.69	0.28	1.62	4.27	5.36	8.09
Tangible Book Value	105.28	27.29	134.27	349.1	360.68	553.64
Tangible Book Value Per Share	0.69	0.28	1.62	4.27	5.36	8.09
Machinery	20.55	23.15	30.88	26.37	25.55	22.72
Construction In Progress	-	-	0.83	2.06	1.57	1.53
Leasehold Improvements	8.4	8.4	11.75	9.65	9.76	8.16

SEC Filings: 10-K · 10-Q